Why would EMS not want to sell the product - there are personal relationships and close knowledge in place with Africa (including Mandela family), as well as ownership of distribution companies in Africa. Really it would be better to 1. forge forwards, distribute and sell, develop Nicosorb; or 2. takeover. Would a "trade sale" be in our best interests, as the product is potentially more valuable in the hands of EMS rather than a third party?
- Forums
- ASX - By Stock
- EMS
- "phase iii clinical field trials"
"phase iii clinical field trials" , page-15
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMS (ASX) to my watchlist
|
|||||
Last
3.0¢ |
Change
0.002(7.14%) |
Mkt cap ! $2.964M |
Open | High | Low | Value | Volume |
3.0¢ | 3.0¢ | 3.0¢ | $2.729K | 90.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 15741 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.029 |
2 | 220000 | 0.028 |
5 | 229711 | 0.027 |
2 | 150000 | 0.026 |
4 | 260040 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 15741 | 2 |
0.032 | 106684 | 2 |
0.033 | 62258 | 2 |
0.035 | 300000 | 1 |
0.040 | 202501 | 1 |
Last trade - 10.45am 12/07/2024 (20 minute delay) ? |
Featured News
EMS (ASX) Chart |